I, Ezgi Başavcı, currently Marie Skłodowska-Curie ITN fellow PhD student at the University of Stavanger and a researcher at Polypure AS, Oslo which is the partner organization of the NOVA-MRI project. My main duty on the project is enhancing the serum stability and biocompatibility of the 19F based contrast agent containing PLGA nanoparticles via monodisperse PEG coating on it for MRI.
After all, I have graduated from a Master of Science Program in Biomedical Engineering and Bioinformatics Program at Istanbul Medipol University in 2020. During my Master’s journey, I have focused on research on an investigation of PEGylated biocompatible Graphene-based polymericand uMUC1 peptide targeted anticancer therapeutic drug and siRNA loaded drug delivery system design, synthesis, characterization, and in-vitro tests. I have taken place in another project which is based on beta-cyclodextrin functionalization to enhance its gene and therapeutics carrying capacity with endosomal escape ability. Additionally, I have taken a Pedagogical Formation Certificate learned the fundamentals of teaching from Marmara University, Istanbul, Turkey in 2019.
In summer 2016, I have done an internship at Prof. Nadrian Seeman’s DNA Nanotechnology Laboratory at New York University (NYU), United States. There, I undertook a project on the design and synthesis of 3D Crystals made from DNA Bricks.
I have earned my bachelor of science degree in Chemistry from Istanbul Technical University (ITU) in 2017 and was a member of Prof. Turan Öztürk’s Organic Material Chemistry Research Group as an undergrad researcher. During these years I was working on the organic synthesis and characterization of heterocyclic compounds and investigating of their usage in the development of electronic and optoelectronic materials for OLEDs, solar cells, electrochromic capacitors.
